Esperante Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Spiral Therapeuticsspiraltx.cominAug 2023
Spiral Therapeutics is a clinical-stage pharmaceutical company developing therapies for balance disorders and hearing loss using its Minimally Invasive Cochlear System (MICS) drug delivery platform.
BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US
Hugo Peris(Founder & CEO)inEugene de Juan(Executive Officer, Director)Lawrence Fritz(Director)
BoardWARREN THALER(Director)JEAN-FREDERIC PAULSEN(Director)Guy Nohra(Director)in
Co-investorsCatalio Capital ManagementAlta Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.